Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 1398, March 1, 2008. doi: 10.1158/0008-5472.CAN-07-2865
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yogev, O.
Right arrow Articles by Shaulian, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yogev, O.
Right arrow Articles by Shaulian, E.

Cell, Tumor, and Stem Cell Biology

DNA Damage–Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway

Orli Yogev1, Keren Saadon1, Shira Anzi1, Kazushi Inoue2 and Eitan Shaulian1

1 Department of Experimental Medicine and Cancer Research, Hebrew University Medical School, Jerusalem, Israel and 2 Departments of Pathology/Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina

Requests for reprints: Eitan Shaulian, Department of Experimental Medicine and Cancer Research, Hebrew University Medical School, Ein Karem, Jerusalem 91120, Israel. Phone: 972-2-6757617; Fax: 972-2-6414583; E-mail: eshaulian{at}md.huji.ac.il.

Key Words: JNK • B23 • p19ARF • redistribution • AP-1

The dynamic behavior of the nucleolus plays a role in the detection of and response to DNA damage of cells. Two nucleolar proteins, p14ARF/p19ARF and B23, were shown to translocate out of the nucleolus after exposure of cells to DNA-damaging agents. This translocation affects multiple cellular functions, such as DNA repair, proliferation, and survival. In this study, we identify a pathway and scrutinize the mechanisms leading to the translocation of these proteins after exposure of cells to DNA-damaging agents. We show that redistribution of B23 and p19ARF after the exposure to genotoxic stress occurs preferentially when the c-Jun-NH2-kinase (JNK) pathway is activated and is inhibited when the JNK pathway is impaired. The stress-induced translocation of alternative reading frame (ARF) is JNK dependent and mediated by two activator proteins, c-Jun and JunB. Thr91 and Thr93 of c-Jun are required for the translocation, but the transcriptional activity of c-Jun is dispensable. Instead, c-Jun interacts with B23 in a dose-dependent manner. c-Jun itself is excluded from the nucleolus in a JNK-dependent manner. Hence, we suggest that c-Jun translocates B23 and ARF from the nucleolus after JNK activation by means of protein interactions. In senescent cells, JNK activity and c-Jun levels are reduced concomitantly with ARF nucleolar accumulation, and UV radiation does not cause the translocation of ARF. [Cancer Res 2008;68(5):1398–406]




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
J. Zhang, Y. Yang, and J. Wu
B23 interacts with PES1 and is involved in nucleolar localization of PES1
Acta Biochim Biophys Sin, November 12, 2009; (2009) gmp096v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. P. Vanderwaal, L. B. Maggi Jr., J. D. Weber, C. R. Hunt, and J. L. Roti Roti
Nucleophosmin Redistribution following Heat Shock: A Role in Heat-Induced Radiosensitization
Cancer Res., August 15, 2009; 69(16): 6454 - 6462.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Robert, F. Dantzer, and B. Reina-San-Martin
Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination
J. Exp. Med., May 11, 2009; 206(5): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Xiong and R. J. Epstein
Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status
Mol. Cancer Ther., April 1, 2009; 8(4): 779 - 785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.